Trial intelligence / Profile preview

Modafinil for Delayed Emergence in OSA Patients

NCT02494102Phase 4Terminated

Sponsor
Penn State Health Milton S. Hershey Medical Center
Start
Feb 2016
Primary completion
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of modafinil in delayed emergence from anesthesia, sponsored by Penn State Health Milton S. Hershey Medical Center. Started Feb 2016; status: terminated.

02

Drugs

modafinil
03

Conditions

delayed emergence from anesthesia

Beyond the preview

Go deeper on NCT02494102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02494102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call